Vimarsana
Biggest News Aggregation in the World

Evaline Kibuchi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaline Kibuchi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaline Kibuchi Today - Breaking & Trending Today

It's a miracle I am alive, gospel musician Peter Machui says of battle with TB - Vimarsana News

It's a miracle I am alive, gospel musician Peter Machui says of battle with TB

The bacteria responsible for TB can develop resistance to the antimicrobial drugs used in its treatment.

Will The World Leaders Walk The Talk To End TB At The Upcoming UN High Level Meeting? - Vimarsana News

Will The World Leaders Walk The Talk To End TB At The Upcoming UN High Level Meeting?

Leaders of all the UN member countries are expected to convene on 22nd September 2023 at the upcoming second United Nations General Assembly High Level Meeting (UNHLM) on TB (the first one was held in September 2018). The theme of this year's UNHLM ...

Pacific.scoop.co.nz » Will The World Leaders Walk The Talk To End TB At The Upcoming UN High Level Meeting? - Vimarsana News

Pacific.scoop.co.nz » Will The World Leaders Walk The Talk To End TB At The Upcoming UN High Level Meeting?

Pacific Scoop provides news and views from the Pacific and New Zealand

WHO distributes new drug to fight multi drug resistant TB as MPs meet in Nairobi to discuss disease - Vimarsana News

WHO distributes new drug to fight multi drug resistant TB as MPs meet in Nairobi to discuss disease

Over 25 per cent of TB deaths occur in the African region and the emergence of multidrug-resistant TB poses a major health security threat.

WHO distributes new drug to fight multidrug-resistant TB as MPs meet in Nairobi to discuss disease - Vimarsana News

WHO distributes new drug to fight multidrug-resistant TB as MPs meet in Nairobi to discuss disease

Over 25 per cent of TB deaths occur in the African region and the emergence of multidrug-resistant TB poses a major health security threat.